ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 19 filers reported holding ARCA BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $163,000 | -63.5% | 326,147 | +0.4% | 0.00% | -66.7% |
| Q4 2017 | $447,000 | +73.3% | 324,847 | +38.3% | 0.00% | +50.0% |
| Q3 2017 | $258,000 | -41.5% | 234,847 | +30.6% | 0.00% | -33.3% |
| Q2 2017 | $441,000 | +465.4% | 179,847 | +476.4% | 0.00% | +200.0% |
| Q1 2017 | $78,000 | -78.5% | 31,200 | -75.2% | 0.00% | -50.0% |
| Q3 2016 | $363,000 | -18.1% | 125,733 | -17.7% | 0.00% | -33.3% |
| Q2 2016 | $443,000 | -28.2% | 152,733 | -15.0% | 0.00% | -25.0% |
| Q1 2016 | $617,000 | – | 179,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 93,258 | $35,000 | 0.02% |
| Tekla Capital Management LLC | 811,227 | $303,000 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 576 | $0 | 0.00% |
| NORTHERN TRUST CORP | 13,986 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 48,679 | $18,000 | 0.00% |
| MORGAN STANLEY | 2,000 | $1,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 219,236 | $82,000 | 0.00% |
| BlackRock Inc. | 865 | $0 | 0.00% |
| Citadel Advisors | 81,938 | $31,000 | 0.00% |